The New Jersey Alliance for Clinical and Translational Science (NJ ACTS) is pleased to announce that three federally-funded grants have been awarded to teams from Princeton University to support translational research aimed at improving health and benefiting other researchers across the region. NJ ACTS, an NIH-funded consortium of Rutgers University, Princeton University, the New Jersey Institute of Technology, and RWJBarnabas Health, helps develop and accelerate the adoption of translational science innovations in early-stage research, diagnostics, treatments, and interventions. Resources and expertise provided by NJ ACTS assists biomedical researchers and clinicians with surmounting technical, practical, or regulatory barriers that slow or prevent their discoveries from being put into action as tangible health solutions.

Read the Full Article by Caitlin Sedwick